Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin
Author:
Funder
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Emberi Eroforrások Minisztériuma
Publisher
Frontiers Media SA
Subject
General Neuroscience
Reference115 articles.
1. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.;Abad;J. Neuroinflammation,2016
2. Diabetic retinopathy.;Antonetti;N. Engl. J. Med.,2012
3. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction.;Arimura;Front. Neuroendocrinol.,1995
4. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.;Atlasz;Ann. N. Y. Acad. Sci.,2010
5. Effects of pituitary adenylate cyclase activating polypeptide and its fragments on retinal degeneration induced by neonatal monosodium glutamate treatment.;Atlasz;Ann. N. Y. Acad. Sci.,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Injectable Gel-PEG hydrogels as promising delivery system for intravitreal PACAP release: Novel therapeutics for unilateral common carotid artery occlusion induced retinal ischemia;Biomedicine & Pharmacotherapy;2024-10
2. The Healthy and Diseased Retina Seen through Neuron–Glia Interactions;International Journal of Molecular Sciences;2024-01-17
3. The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease;Pharmaceutics;2023-07-28
4. Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases;Biophysical Reviews;2022-06
5. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) in corneal epithelial regeneration and signal transduction in rats;International Journal of Peptide Research and Therapeutics;2022-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3